The possibility of reprogramming differentiated adult cells which are limited in their
functions, into cells capable of generating all cell types of the adult organism has opened
new horizons in regenerative medicine. However, for a safe use of reprogrammed cells
in new clinical applications, the reprogramming process remains to be improved. We
have showed that the use of the protein Cited2 in during the reprogramming procedure
increases the efficiency and homogenizes the process.
